subscribeSubscribe
price-trendAsk Us
Accord Healthcare`s Degarelix Accord (degarelix) Receives Approval in Europe

Accord Healthcare`s Degarelix Accord (degarelix) Receives Approval in Europe
EMA
08 Nov 2023
Share Share
UCLA researchers to study prostate cancer drug for Covid-19

UCLA researchers to study prostate cancer drug for Covid-19
CLINICALTRIALSARENA
18 May 2020
Share Share
FDA Confirms Paragraph IV Patent Challenge of Firmagon 22201 (Degarelix Acetate 80 mg/vial and 120 mg/vial)Powder for Injection

FDA Confirms Paragraph IV Patent Challenge of Firmagon 22201 (Degarelix Acetate 80 mg/vial and 120 mg/vial)Powder for Injection

FDA
15 Feb 2020
Share Share
Myovant`s oral prostate cancer drug matches incumbent in phase 3

Myovant`s oral prostate cancer drug matches incumbent in phase 3
N. P Taylor FIERCE BIOTECH
20 Nov 2019
Share Share
Myovant`s oral prostate cancer drug matches incumbent in phase 3

Myovant`s oral prostate cancer drug matches incumbent in phase 3
N. P Taylor FIERCE BIOTECH
20 Oct 2019
Share Share
Myovant`s oral prostate cancer drug matches incumbent in phase 3

Myovant`s oral prostate cancer drug matches incumbent in phase 3
N. P Taylor FIERCE BIOTECH
20 Oct 2019
Share Share
Ferring pits prostate cancer drug against AbbVie`s Lupron in PhIIIb CV outcomes

Ferring pits prostate cancer drug against AbbVie`s Lupron in PhIIIb CV outcomes
Nick Paul Taylor FIERCE BIOTECH
10 Feb 2016
Share Share
NICE backs Bayer`s Xofigo but rejects Ferring`s Firmagon

NICE backs Bayer`s Xofigo but rejects Ferring`s Firmagon
Selina Mckee PHARMA TIMES
08 Jun 2015
Share Share